What will be the key issues in the CDMO space for parenteral drug manufacturing in 2025? The latest episode of DCAT Value Chain Insights’ original podcast Production to Prescription, examines the latest hot-button issues: 

How are supply and demand shaping up for sterile manufacturing and aseptic fill–finish in the CDMO/CMO sector? Is a capacity crunch or capacity ease in the making? And how will hot-product areas, such as GLP-1 agonist impact market fundamentals.  

This episode features Ian Tzeng, Managing Director and Partner, L.E.K. Consulting, where he focuses on healthcare and life sciences, including pharmaceuticals, vaccines, and leads L.E.K.’s Pharmaceutical Contract Services practice. 

DCAT Value Chain Insights’ Production to Prescription podcast features thought leaders with expert views on the major happenings impacting the global bio/pharmaceutical manufacturing value chain and industry performance. 

Click here for the latest episode and here for the full 2025 schedule.